UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $38.58 Million Holdings in Evolent Health, Inc. (NYSE:EVH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 13.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,364,298 shares of the technology company’s stock after selling 210,301 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Evolent Health were worth $38,582,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Principal Financial Group Inc. grew its holdings in shares of Evolent Health by 3.2% during the second quarter. Principal Financial Group Inc. now owns 15,594 shares of the technology company’s stock worth $298,000 after purchasing an additional 480 shares during the last quarter. SeaCrest Wealth Management LLC lifted its position in Evolent Health by 6.3% during the 2nd quarter. SeaCrest Wealth Management LLC now owns 10,200 shares of the technology company’s stock worth $195,000 after buying an additional 600 shares in the last quarter. Arizona State Retirement System lifted its position in Evolent Health by 2.3% during the 2nd quarter. Arizona State Retirement System now owns 29,083 shares of the technology company’s stock worth $556,000 after buying an additional 649 shares in the last quarter. Covestor Ltd grew its holdings in Evolent Health by 138.1% during the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after acquiring an additional 826 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Evolent Health by 5,365.5% in the 3rd quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock valued at $45,000 after acquiring an additional 1,556 shares in the last quarter.

Evolent Health Trading Down 7.9 %

Shares of NYSE EVH opened at $11.71 on Wednesday. Evolent Health, Inc. has a twelve month low of $11.17 and a twelve month high of $35.00. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of -12.87 and a beta of 1.45. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.58. The company’s fifty day moving average is $21.12 and its 200-day moving average is $23.26.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on EVH shares. Royal Bank of Canada reiterated an “outperform” rating and set a $20.00 target price on shares of Evolent Health in a research report on Tuesday, November 12th. Citigroup dropped their target price on Evolent Health from $33.00 to $21.00 and set a “buy” rating for the company in a research report on Wednesday, November 13th. Stephens cut Evolent Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $38.00 to $16.00 in a report on Friday, November 8th. Truist Financial reissued a “buy” rating and set a $33.00 price objective on shares of Evolent Health in a report on Tuesday, August 27th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Evolent Health from $45.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $26.18.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.